Celltrend

Key figures

- founded in 1998

- biotechnology company and a contract research organisation for the pharmaceutical industry

- performs cell based Bioassays with the focus on oncology and immunology.

- develops, produces, and distributes Immuno-Assays e.g. ELISAs 

- certified according to ISO 9001:2008, ISO 13485:2003 (medical devices), and ISO 13485:2003 CMDR (Canada Medical Devices Regulation)

- developed the ELISA for the determination of Auto-Antibodies against the Angiotensin-II-Receptor-I (assay is patented worldwide)

We offer

- Cell culture systems for research on active substances (Bioassays)
- Development and production of antibody-based detection systems
- Individual pharmacotherapy (outsourced in the Center of molecular Oncology)